Imagine seeing a doctor before you even step into a hospital.
A patient uploads medical records and symptoms on a phone, and AI provides initial triage and risk alerts. By the time the patient arrives, the doctor already has a structured case summary. After treatment, the system continues with follow-up reminders and medication alerts, turning fragmented care into a more connected process.
For many, such a scenario may still sound futuristic. In China, however, it is moving more quickly from vision to reality.
The country recently took a step in that direction with the launch of its first AI hospital in Boao, South China’s Hainan Province, on March 26, the Xinhua News Agency reported. On the same day, a consensus on AI hospitals was released during the 2026 Zhongguancun Forum (ZGC Forum) in Beijing, offering the first internationally recognized definition of an “AI hospital,” according to news outlet china.com.cn.
According to the consensus, an AI hospital is a new type of smart healthcare model in which AI is embedded into the system itself, linking offline medical expertise with the broader reach of online services to deliver more proactive and continuous care.
Meanwhile, concepts such as AI hospitals, AI doctor assistants, intelligent follow-up systems and AI-assisted diagnosis have been gaining ground in hospitals and healthcare settings across China.
This latest wave of change is not unfolding in isolation. In November 2025, China’s National Health Commission and other relevant authorities issued a guideline on promoting and regulating the application of AI in healthcare, calling for AI to support continuous services across prevention, diagnosis, rehabilitation and health management.
In other words, China’s push to bring AI into healthcare is no longer limited to scattered experiments by individual hospitals or companies. Under policy guidance, it is moving toward a more systematic and better regulated phase.
As AI enters hospitals, works alongside doctors and reaches patients more directly, what exactly will it change? As the technology advances rapidly, how should standards, regulation, accountability and ethical boundaries keep pace?
Super AI hospital
“Instead of patients searching everywhere for medicine, the right medicine can now ‘find’ the right patients,” Zhang Bangqun, general manager of the Super AI Hospital in Boao, said in describing the significance of the new hospital.
The hospital, formally named Hainan Boao Super Digital Intelligence Hospital Management Co, is located in Boao Lecheng International Medical Tourism Pilot Zone. According to news outlet China City Network, the project was jointly funded by several domestic companies, with core technical support provided by related firms.
In Zhang’s view, the most immediate change brought by the hospital is not simply the insertion of AI into a hospital setting, but an attempt to reorganize the way patients gain access to medical resources.
“In the past, patients who wanted access to the world’s latest specially licensed drugs and medical devices might have had to visit multiple hospitals and wait for months. Now, AI helps find them, match them and track them,” he told the Global Times.
According to materials provided by the hospital to the Global Times, the Super AI Hospital has built an AI hospital intelligence network system and a MaaS (Mobility-as-a-Service) results promotion platform, in an effort to connect the entire chain from technology research and development to clinical application.
Relying on core modules embedded in the platform, including “thousand-disease agents,” “thousand-hospital agents” and an AI assistant for specially licensed drugs and medical devices, the system can track the latest global drug and device information around the clock, identify patients with relevant indications through intelligent assessment, and match them with more suitable treatment plans.
At the same time, a related app connects providers and users of medical AI scenarios, seeking to move more high-quality technologies from the laboratory into real-world medical settings and reduce the extra burden patients face due to information gaps and cross-regional treatment-seeking.
AI hospitals are also taking root in fertile ground. In service terms, the hospital has adopted a three-step model: local consultation, treatment in Lecheng and home follow-up. The idea is to reduce unnecessary travel while improving the flow of medical resources, according to Zhang.
Approved by the State Council in 2013, the Lecheng pilot zone is the country’s only special medical zone on the southern tropical island of Hainan, according to Xinhua. Today, more than 30 medical institutions have established operations in the pilot zone, including top-tier hospitals from Shanghai and East China’s Shandong Province, as well as other renowned healthcare providers from China and abroad, the Global Times learned from the pilot zone.
Drawing upon its special policy advantages, the pilot zone has become a key gateway for the entry of global medicines and medical devices not yet approved elsewhere in China, according to the pilot zone. Xinhua reported in January that more than 200,000 patients had benefited from Lecheng, which had introduced more than 500 innovative medicines and medical devices approved overseas but not yet available domestically.
Leave a Reply